ID SYI_CAMC5 Reviewed; 919 AA. AC A7GX26; DT 15-JAN-2008, integrated into UniProtKB/Swiss-Prot. DT 11-SEP-2007, sequence version 1. DT 27-MAR-2024, entry version 99. DE RecName: Full=Isoleucine--tRNA ligase {ECO:0000255|HAMAP-Rule:MF_02002}; DE EC=6.1.1.5 {ECO:0000255|HAMAP-Rule:MF_02002}; DE AltName: Full=Isoleucyl-tRNA synthetase {ECO:0000255|HAMAP-Rule:MF_02002}; DE Short=IleRS {ECO:0000255|HAMAP-Rule:MF_02002}; GN Name=ileS {ECO:0000255|HAMAP-Rule:MF_02002}; GN OrderedLocusNames=Ccur92_04640; ORFNames=CCV52592_0977; OS Campylobacter curvus (strain 525.92). OC Bacteria; Campylobacterota; Epsilonproteobacteria; Campylobacterales; OC Campylobacteraceae; Campylobacter. OX NCBI_TaxID=360105; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=525.92; RA Fouts D.E., Mongodin E.F., Puiu D., Sebastian Y., Miller W.G., RA Mandrell R.E., Lastovica A.J., Nelson K.E.; RT "Genome sequence of Campylobacter curvus 525.92 isolated from human RT feces."; RL Submitted (JUL-2007) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Catalyzes the attachment of isoleucine to tRNA(Ile). As IleRS CC can inadvertently accommodate and process structurally similar amino CC acids such as valine, to avoid such errors it has two additional CC distinct tRNA(Ile)-dependent editing activities. One activity is CC designated as 'pretransfer' editing and involves the hydrolysis of CC activated Val-AMP. The other activity is designated 'posttransfer' CC editing and involves deacylation of mischarged Val-tRNA(Ile). CC {ECO:0000255|HAMAP-Rule:MF_02002}. CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + L-isoleucine + tRNA(Ile) = AMP + diphosphate + L- CC isoleucyl-tRNA(Ile); Xref=Rhea:RHEA:11060, Rhea:RHEA-COMP:9666, CC Rhea:RHEA-COMP:9695, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, CC ChEBI:CHEBI:58045, ChEBI:CHEBI:78442, ChEBI:CHEBI:78528, CC ChEBI:CHEBI:456215; EC=6.1.1.5; Evidence={ECO:0000255|HAMAP- CC Rule:MF_02002}; CC -!- COFACTOR: CC Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000255|HAMAP- CC Rule:MF_02002}; CC Note=Binds 1 zinc ion per subunit. {ECO:0000255|HAMAP-Rule:MF_02002}; CC -!- SUBUNIT: Monomer. {ECO:0000255|HAMAP-Rule:MF_02002}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_02002}. CC -!- DOMAIN: IleRS has two distinct active sites: one for aminoacylation and CC one for editing. The misactivated valine is translocated from the CC active site to the editing site, which sterically excludes the CC correctly activated isoleucine. The single editing site contains two CC valyl binding pockets, one specific for each substrate (Val-AMP or Val- CC tRNA(Ile)). {ECO:0000255|HAMAP-Rule:MF_02002}. CC -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase family. CC IleS type 1 subfamily. {ECO:0000255|HAMAP-Rule:MF_02002}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; CP000767; EAT99831.1; -; Genomic_DNA. DR RefSeq; WP_011991961.1; NC_009715.2. DR AlphaFoldDB; A7GX26; -. DR SMR; A7GX26; -. DR STRING; 360105.CCV52592_0977; -. DR KEGG; ccv:CCV52592_0977; -. DR HOGENOM; CLU_001493_7_0_7; -. DR OrthoDB; 9810365at2; -. DR Proteomes; UP000006380; Chromosome. DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. DR GO; GO:0002161; F:aminoacyl-tRNA editing activity; IEA:InterPro. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule. DR GO; GO:0004822; F:isoleucine-tRNA ligase activity; IEA:UniProtKB-UniRule. DR GO; GO:0000049; F:tRNA binding; IEA:InterPro. DR GO; GO:0008270; F:zinc ion binding; IEA:UniProtKB-UniRule. DR GO; GO:0006428; P:isoleucyl-tRNA aminoacylation; IEA:UniProtKB-UniRule. DR CDD; cd07960; Anticodon_Ia_Ile_BEm; 1. DR CDD; cd00818; IleRS_core; 1. DR Gene3D; 1.10.730.20; -; 1. DR Gene3D; 3.40.50.620; HUPs; 2. DR Gene3D; 3.90.740.10; Valyl/Leucyl/Isoleucyl-tRNA synthetase, editing domain; 1. DR HAMAP; MF_02002; Ile_tRNA_synth_type1; 1. DR InterPro; IPR001412; aa-tRNA-synth_I_CS. DR InterPro; IPR002300; aa-tRNA-synth_Ia. DR InterPro; IPR033708; Anticodon_Ile_BEm. DR InterPro; IPR002301; Ile-tRNA-ligase. DR InterPro; IPR023585; Ile-tRNA-ligase_type1. DR InterPro; IPR013155; M/V/L/I-tRNA-synth_anticd-bd. DR InterPro; IPR014729; Rossmann-like_a/b/a_fold. DR InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd. DR InterPro; IPR009008; Val/Leu/Ile-tRNA-synth_edit. DR NCBIfam; TIGR00392; ileS; 1. DR PANTHER; PTHR42765:SF1; ISOLEUCINE--TRNA LIGASE, MITOCHONDRIAL; 1. DR PANTHER; PTHR42765; SOLEUCYL-TRNA SYNTHETASE; 1. DR Pfam; PF08264; Anticodon_1; 1. DR Pfam; PF00133; tRNA-synt_1; 1. DR PRINTS; PR00984; TRNASYNTHILE. DR SUPFAM; SSF47323; Anticodon-binding domain of a subclass of class I aminoacyl-tRNA synthetases; 1. DR SUPFAM; SSF52374; Nucleotidylyl transferase; 1. DR SUPFAM; SSF50677; ValRS/IleRS/LeuRS editing domain; 1. DR PROSITE; PS00178; AA_TRNA_LIGASE_I; 1. PE 3: Inferred from homology; KW Aminoacyl-tRNA synthetase; ATP-binding; Cytoplasm; Ligase; Metal-binding; KW Nucleotide-binding; Protein biosynthesis; Reference proteome; Zinc. FT CHAIN 1..919 FT /note="Isoleucine--tRNA ligase" FT /id="PRO_1000022053" FT MOTIF 59..69 FT /note="'HIGH' region" FT MOTIF 611..615 FT /note="'KMSKS' region" FT BINDING 570 FT /ligand="L-isoleucyl-5'-AMP" FT /ligand_id="ChEBI:CHEBI:178002" FT /evidence="ECO:0000255|HAMAP-Rule:MF_02002" FT BINDING 614 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|HAMAP-Rule:MF_02002" FT BINDING 893 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000255|HAMAP-Rule:MF_02002" FT BINDING 896 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000255|HAMAP-Rule:MF_02002" FT BINDING 908 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000255|HAMAP-Rule:MF_02002" FT BINDING 911 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000255|HAMAP-Rule:MF_02002" SQ SEQUENCE 919 AA; 104842 MW; C211CC0ADD97716E CRC64; MDYKDTLLLP ATDFPMRGDL PKNEPIRLKS WYEERKIYEK MKSKRAGAAK NFAIHDGPPY ANGHLHIGHA LNKILKDIIT KTHYFFGENV RYVPGWDCHG LPIEQQVEVK LGDKKKELSK TQIRELCRAH AREFIDIQRE EFKALGIIGD FENPYMTMKF EFEADIYRSL CEIAKKGLLI ERSKPVYWSW AAKSALAEAE VEYEDKEDYS IYVAFELDSD ALAKLGVKLA KAVIWTTTPW TLPANQAISL KPDEIYVLTS ENLIFAKPLL ESLVNLGLTK GEILKEFVSN ELENTHAINP LNDRKSRFLL GDHVLMDGGT GLVHTAPGHG EDDYYICLRY GFKEILMPVD DGGLYDETLK AHSLLRADVV DSFVGMHIFK ANEKIIELLG ENLLHVSKFT HSYPFCWRTH KPVIYRATKQ WFIAMDEPKL GGKTLREVAR GELENVKFYP SVGIKRIGSM IENRPDWCIS RQRDWGVPIA FFRRKDTKEP IFEPKILEHI AKIFEQKGAD AWWDMSVEEL LAPDSGFEAK NLEKVMDILD VWFDSGSTWH AVLNSKNYDA GSYPADMYLE GSDQHRGWFQ SSLLVSTAIN SHAPYKNILT HGFTVDENGQ KMSKSKGNVV APQDVAKSYG VEILRLWVGL SDYSSDLKIS ENILKQVSEQ YRKIRNTIRF LLANVNDLET IGTDFGFLDQ WILGRAKRVF DEASKCFRAY DFSKGFNLLL NFLSADLSGI YLDICKDRLY CDAKDSPRRR SAQSAMAIIT KSLLPLIAPT LTYTVDEVMD YAPAIIKGDA KDAFDLVYEP INFDFDVEDE LLFASREKFF ELIDALKKDK KIKSTLELVL ETTSSKILDY DSVERADIYM VSDVHRYSGN EGLGEFEIDG EKFKIVLSDA SKCPRCWKFN AIIDGSTCER CSEVLNSVC //